Chemours Co. Files Definitive Proxy Statement, Announces Leadership Changes

Ticker: CC · Form: DEF 14A · Filed: Apr 11, 2024 · CIK: 1627223

Chemours Co DEF 14A Filing Summary
FieldDetail
CompanyChemours Co (CC)
Form TypeDEF 14A
Filed DateApr 11, 2024
Risk Level
Pages15
Reading Time17 min
Key Dollar Amounts$0, $5.6 million
Sentimentneutral

Sentiment: neutral

Topics: proxy statement, leadership change, CEO appointment, internal review, shareholder engagement

TL;DR

<b>Chemours Co. has filed its definitive proxy statement, detailing leadership transitions including the appointment of Denise Dignam as CEO following an internal review.</b>

AI Summary

Chemours Co (CC) filed a Proxy Statement (DEF 14A) with the SEC on April 11, 2024. Chemours Co. filed its Definitive Proxy Statement on April 11, 2024. The company announced leadership changes following an internal review led by the Audit Committee. Three senior management members were placed on administrative leave in late February. Denise Dignam was appointed President and Chief Executive Officer on March 22, 2024. Denise Dignam has prior experience leading Chemours' Titanium Technologies and Advanced Performance Materials businesses.

Why It Matters

For investors and stakeholders tracking Chemours Co, this filing contains several important signals. The proxy statement provides shareholders with information regarding upcoming meetings and board nominations, allowing them to make informed voting decisions. The leadership changes signal a period of transition and potential strategic shifts within the company, which shareholders will want to monitor.

Risk Assessment

Risk Level: — Chemours Co shows moderate risk based on this filing. The company has undergone significant senior management changes and an internal review, indicating potential underlying issues that could impact future performance.

Analyst Insight

Shareholders should closely examine the proxy statement for details on board nominees and executive compensation to assess the company's strategic direction and governance.

Key Numbers

  • 2024-04-11 — Filing Date (Date the Definitive Proxy Statement was filed.)
  • 2024-03-22 — CEO Appointment Date (Date Denise Dignam was appointed CEO.)
  • Late February 2024 — Management Leave (Period when three senior management members were placed on administrative leave.)

Key Players & Entities

  • Chemours Co. (company) — Registrant filing the proxy statement.
  • Denise Dignam (person) — Appointed President and Chief Executive Officer.
  • Audit Committee (company) — Led the internal review.

FAQ

When did Chemours Co file this DEF 14A?

Chemours Co filed this Proxy Statement (DEF 14A) with the SEC on April 11, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Chemours Co (CC).

Where can I read the original DEF 14A filing from Chemours Co?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Chemours Co.

What are the key takeaways from Chemours Co's DEF 14A?

Chemours Co filed this DEF 14A on April 11, 2024. Key takeaways: Chemours Co. filed its Definitive Proxy Statement on April 11, 2024.. The company announced leadership changes following an internal review led by the Audit Committee.. Three senior management members were placed on administrative leave in late February..

Is Chemours Co a risky investment based on this filing?

Based on this DEF 14A, Chemours Co presents a moderate-risk profile. The company has undergone significant senior management changes and an internal review, indicating potential underlying issues that could impact future performance.

What should investors do after reading Chemours Co's DEF 14A?

Shareholders should closely examine the proxy statement for details on board nominees and executive compensation to assess the company's strategic direction and governance. The overall sentiment from this filing is neutral.

How does Chemours Co compare to its industry peers?

Chemours operates in the chemical industry, a sector subject to regulatory scrutiny and market volatility.

Are there regulatory concerns for Chemours Co?

As a chemical company, Chemours is subject to environmental, health, and safety regulations.

Risk Factors

  • Leadership Transition [medium — operational]: The company has experienced significant changes in senior management, including the appointment of a new CEO and administrative leave for other executives, following an internal review.

Industry Context

Chemours operates in the chemical industry, a sector subject to regulatory scrutiny and market volatility.

Regulatory Implications

As a chemical company, Chemours is subject to environmental, health, and safety regulations.

What Investors Should Do

  1. Review the full proxy statement for details on board proposals and director nominees.
  2. Analyze executive compensation changes and their alignment with company performance.
  3. Monitor future communications for updates on the impact of leadership changes on business strategy.

Key Dates

  • 2024-04-11: Filing of Definitive Proxy Statement — Provides shareholders with information for upcoming votes and details on company governance.
  • 2024-03-22: Appointment of Denise Dignam as CEO — Marks a significant leadership change following an internal review.
  • Late February 2024: Senior Management Placed on Leave — Preceded the internal review and subsequent leadership changes.

Year-Over-Year Comparison

This filing is a DEF 14A, indicating it's a proxy statement, and does not contain financial results from a prior period within this document.

Filing Stats: 4,353 words · 17 min read · ~15 pages · Grade level 16.1 · Accepted 2024-04-11 16:06:11

Key Financial Figures

  • $0 — hief Financial Officer Jonathan Lock to $0. Negative Discretion for PSUs: The CL
  • $5.6 million — Impact In 2023, awarded approximately $5.6 million in grants in support of our Vibrant Com

Filing Documents

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 29

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 31 Compensation Discussion and Analysis 31

Executive Compensation Tables

Executive Compensation Tables 57 Compensation and Leadership Development Committee Report 72 PROPOSAL 2—ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION 79 PROPOSAL 3—RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 80 Fees Paid to Independent Registered Public Accounting Firm 80 Audit Committee's Pre-Approval Policies and Procedures 80 Report of the Audit Committee 81 CERTAIN RELATIONSHIPS AND TRANSACTIONS 82 OTHER INFORMATION 83 Other Business that May Come Before the Meeting 83 2025 Annual Meeting of Shareholders 83 Annual Report on Form 10-K 83 GENERAL INFORMATION ABOUT THE MEETING 84 TABLE OF CONTENTS Proxy Summary Details of the Annual Meeting of Shareholders (including any adjournments and postponements) for The Chemours Company ("Chemours" or the "Company"), including the location of the meeting and the proposals its shareholders will vote upon at the meeting are listed below. Time and Date Place: 10:00 a.m. (Eastern Time) on Tuesday, May 21, 2024 Virtual Meeting Only—No Physical Location MANAGEMENT PROPOSALS BOARD VOTE RECOMMENDATION SEE PAGE Proposal 1—Election of Directors FOR EACH NOMINEE 7 Proposal 2—Advisory Vote on Executive Compensation FOR 79 Proposal 3—Ratification of Independent Registered Public Accounting Firm FOR 80 Voting As a shareholder, you are invited to participate in the Annual Meeting and are entitled and encouraged to vote on the proposals described in this Proxy Statement. Only holders of record of Chemours common stock at the close of business on April 3, 2024 (the "Record Date") are entitled to vote at the Annual Meeting. Each outstanding share of common stock is entitled to one vote. If your shares are registered directly in your own name with the Company's transfer agent, Computershare Trust Company, N.A., you are considered a "shareholder of record" with respect to those shares, and the Notice ha

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.